DK532078A - Fremgangsmaade til fremstilling af overtrukne partikler - Google Patents
Fremgangsmaade til fremstilling af overtrukne partiklerInfo
- Publication number
- DK532078A DK532078A DK532078A DK532078A DK532078A DK 532078 A DK532078 A DK 532078A DK 532078 A DK532078 A DK 532078A DK 532078 A DK532078 A DK 532078A DK 532078 A DK532078 A DK 532078A
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- coated particles
- preparing coated
- preparing
- particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5105877 | 1977-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK532078A true DK532078A (da) | 1979-06-09 |
Family
ID=10458491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK532078A DK532078A (da) | 1977-12-08 | 1978-11-28 | Fremgangsmaade til fremstilling af overtrukne partikler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4223006A (da) |
| EP (1) | EP0002574B1 (da) |
| JP (1) | JPS54113419A (da) |
| AU (1) | AU522918B2 (da) |
| CA (1) | CA1132048A (da) |
| DE (1) | DE2862210D1 (da) |
| DK (1) | DK532078A (da) |
| IE (1) | IE47687B1 (da) |
| IL (1) | IL56077A (da) |
| NZ (1) | NZ189022A (da) |
| PH (1) | PH15215A (da) |
| ZA (1) | ZA786694B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4758437A (en) * | 1981-12-23 | 1988-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Composition for long acting nicardipine preparation and process of producing the composition |
| DE3314003A1 (de) * | 1983-04-18 | 1984-10-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung |
| IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4828882A (en) * | 1987-03-16 | 1989-05-09 | Canadian Patents & Developments Limited | Particle encapsulation technique |
| GB9416600D0 (en) * | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
| WO1997022408A1 (en) * | 1995-12-20 | 1997-06-26 | Remi Cornwall | A versatile physical phase changing device |
| AU5135898A (en) * | 1996-12-03 | 1998-06-29 | Schering-Plough Kabushiki Kaisha | Controlled release matrix tablet and method for its preparation |
| WO1999025343A1 (en) * | 1997-11-17 | 1999-05-27 | Gist-Brocades B.V. | Granules comprising clavulanate and one or more excipients |
| US6979735B1 (en) * | 1999-04-01 | 2005-12-27 | Dsm N.V. | Agglomerates by crystallization |
| US6426342B2 (en) * | 1999-08-16 | 2002-07-30 | Revaax Pharmaceuticals, Llc | Use of β-lactamase inhibitors as neuroprotectants |
| ATE319447T1 (de) * | 1999-08-16 | 2006-03-15 | Revaax Pharmaceuticals Llc | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen |
| PL360254A1 (en) * | 2000-10-20 | 2004-09-06 | Biochemie Gesellschaft M.B.H. | Pharmaceutical compositions |
| US20070264346A1 (en) * | 2006-02-16 | 2007-11-15 | Flamel Technologies | Multimicroparticulate pharmaceutical forms for oral administration |
| AU2008317315A1 (en) * | 2007-10-26 | 2009-04-30 | Rexahn Pharmaceuticals, Inc. | Pharmaceutical formulation of clavulanic acid |
| MX2011011459A (es) * | 2009-04-29 | 2011-11-18 | Rexahn Pharmaceuticals Inc | Formulacion de clavulanato para neuroproteccion y tratamiento de trastornos neurodegenerativos. |
| WO2018013870A1 (en) | 2016-07-14 | 2018-01-18 | Achaogen, Inc. | Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2410417A (en) * | 1944-03-04 | 1946-11-05 | Lever Brothers Ltd | Vitamin and mineral dietary supplement and method of making |
| US2811483A (en) * | 1954-12-09 | 1957-10-29 | Pfizer & Co C | Pharmaceutical composition and process for preparing the same |
| NO98434A (da) * | 1959-04-30 | |||
| GB978264A (da) * | 1960-02-26 | |||
| US3400185A (en) * | 1965-04-08 | 1968-09-03 | Bristol Myers Co | Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof |
| DE1492034A1 (de) * | 1965-05-18 | 1969-02-20 | Merck Ag E | Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln |
| US3553313A (en) * | 1966-12-21 | 1971-01-05 | Luis Picas Tort | Manufacture of granulate feed |
| ZA718014B (en) * | 1970-12-23 | 1972-08-30 | Beecham Group Ltd | Pharmaceutical formulations |
| US3909444A (en) * | 1971-08-05 | 1975-09-30 | Ncr Co | Microcapsule |
| US4016254A (en) * | 1972-05-19 | 1977-04-05 | Beecham Group Limited | Pharmaceutical formulations |
| BE791458A (fr) * | 1972-07-31 | 1973-05-16 | Merck & Co Inc | Produit microencapsule |
| DE2406625C3 (de) * | 1973-02-27 | 1979-11-08 | Zenyaku Kogyo K.K., Tokio | Verfahren zum Überziehen von festen Teilchen mit einem im Verdauungstrakt löslichen Film und Vorrichtung zu seiner Durchführung |
| US4123382A (en) * | 1973-05-25 | 1978-10-31 | Merck & Co., Inc. | Method of microencapsulation |
| GB1479655A (en) * | 1974-03-08 | 1977-07-13 | Beecham Group Ltd | Antibiotic preparations |
| GB1529913A (en) * | 1976-02-04 | 1978-10-25 | Beecham Group Ltd | Beta-lactam compounds |
-
1978
- 1978-11-27 NZ NZ189022A patent/NZ189022A/xx unknown
- 1978-11-28 DK DK532078A patent/DK532078A/da not_active Application Discontinuation
- 1978-11-28 ZA ZA00786694A patent/ZA786694B/xx unknown
- 1978-11-29 IL IL56077A patent/IL56077A/xx unknown
- 1978-12-01 DE DE7878300715T patent/DE2862210D1/de not_active Expired
- 1978-12-01 EP EP78300715A patent/EP0002574B1/en not_active Expired
- 1978-12-04 US US05/965,865 patent/US4223006A/en not_active Expired - Lifetime
- 1978-12-05 JP JP15093178A patent/JPS54113419A/ja active Pending
- 1978-12-05 PH PH21891A patent/PH15215A/en unknown
- 1978-12-07 IE IE2422/78A patent/IE47687B1/en unknown
- 1978-12-08 CA CA317,652A patent/CA1132048A/en not_active Expired
- 1978-12-08 AU AU42361/78A patent/AU522918B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0002574B1 (en) | 1983-03-23 |
| AU522918B2 (en) | 1982-07-01 |
| IE782422L (en) | 1979-06-08 |
| IL56077A0 (en) | 1979-01-31 |
| JPS54113419A (en) | 1979-09-05 |
| IL56077A (en) | 1981-09-13 |
| PH15215A (en) | 1982-09-27 |
| IE47687B1 (en) | 1984-05-30 |
| AU4236178A (en) | 1979-06-21 |
| CA1132048A (en) | 1982-09-21 |
| US4223006A (en) | 1980-09-16 |
| NZ189022A (en) | 1981-11-19 |
| DE2862210D1 (en) | 1983-04-28 |
| ZA786694B (en) | 1979-10-31 |
| EP0002574A1 (en) | 1979-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK155733C (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater | |
| DK349478A (da) | Fremgangsmaade til fremstilling af oligoimider | |
| DK207279A (da) | Fremgangsmaade til fremstilling af e-vitaminpulver | |
| DK155279C (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater | |
| DK110778A (da) | Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer | |
| DK361878A (da) | Fremgangsmaade til fremstilling af overtrukne praeparater | |
| DK306978A (da) | Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner | |
| DK532078A (da) | Fremgangsmaade til fremstilling af overtrukne partikler | |
| DK569678A (da) | Fremgangsmaade til fremstilling af 2alfa-cyano-3-oxosteroider | |
| DK484677A (da) | Fremgangsmaade til fremstilling af furokumariner | |
| DK145701C (da) | Fremgangsmaade til fremstilling af ergotalkaloider | |
| DK466878A (da) | Fremgangsmaade til fremstilling af 0-methallyloxyphenol | |
| DK237978A (da) | Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer | |
| DK154949C (da) | Fremgangsmaade til fremstilling af trifluormethylphenoler | |
| DK436978A (da) | Fremgangsmaade til fremstilling af sarcosinoxidase | |
| DK364578A (da) | Fremgangsmaade til fremstilling af hydroxyphenylhydantoin | |
| DK385478A (da) | Fremgangsmaade til fremstilling af dibenzocycloocteniminer | |
| DK248978A (da) | Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin | |
| DK147406C (da) | Analogifremgangsmaade til fremstilling af 7alfa-acylthio-17beta-hydroxy-4-androsten-3-oner | |
| DK383978A (da) | Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidin-4-oner | |
| DK339777A (da) | Fremgangsmaade til fremstilling af 2-benzylperhydroazepiner | |
| DK144884C (da) | Fremgangsmaade til fremstilling af 3-bromphthalid | |
| DK158976C (da) | Fremgangsmaade til fremstilling af alfa-cyanobenzyl | |
| DK195877A (da) | Fremgangsmaade til fremstilling af di-n-propylacetonitril | |
| DK521578A (da) | Fremgangsmaade til fremstilling af phenylbutenoner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |